US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic

By Jacob Gronholt-Pedersen COPENHAGEN (Reuters) -Vaccine maker Bavarian Nordic (CSE:BAVA) expects the incoming Trump administration to boost biodefence funding despite the nomination of Robert F. Kennedy Jr., a vaccine sceptic,…